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Abstract
Object To investigate the effect of water suppression on the hepatic lipid quantification, using the
LCModel.
Material and Methods MR spectra with and without water suppression were acquired in the liver of
mice at 4.7 T and patients at 3 T, and processed with the LCModel. The Crame´r-Rao Lower Bound
(CRLB) values of the seven lipid resonances were determined to assess the impact of water suppression
on hepatic lipid quantification. A paired t-test was used for comparison between the CRLBs obtained
with and without water suppression.
Results For the preclinical data, in the high (low) fat fraction subset an overall impairment in hepatic
lipid quantification, i.e. an increase of CRLBs, (no significant change of CRLBs) was observed in
spectra acquired with water suppression. For the clinical data, there were no substantial changes in
the CRLB with water suppression. Because i) the water suppression does not overall improve the
quantification of the lipid resonances and ii) the MR spectrum without water suppression is always
acquired for fat fraction calculation, the optimal data-acquisition strategy for liver MRS is to acquire
only the MR spectrum without water suppression.
Conclusion For quantification of hepatic lipid resonances, it is advantageous to perform MR spec-
troscopy without water suppression in a clinical and preclinical scenario (at moderate fields).
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1 Introduction
Obesity is rapidly becoming one of the major health concerns worldwide. An increasing morbidity
and mortality connected with many obesity-related diseases, including type-2 diabetes, hypertension
and non-alcoholic fatty liver disease (NAFLD) have been observed in recent years [1]. Fuelled by this
worldwide health problem, there has been a growing interest in lipid metabolism, both in the clinical
and research settings, with particular focus on the quantification of lipids in liver [2–4].
For many years, biochemical and histochemical analyses of biopsies have been the gold standard for
the lipid quantification. In the last decade, magnetic resonance imaging (MRI) and spectroscopy
(MRS) have emerged as the methods of choice for assessment of lipid content (i.e., fat fraction (FF))
in liver [5–8]. The clear advantage of MR techniques over biopsies is that the MRI and MRS are non-
invasive, thus can be performed repeatedly in longitudinal studies without risk of complications [9].
MRI and MRS provide complementary information regarding hepatic lipids. Using MRI, the FF can
be determined over the whole liver volume, whereas with MRS the FF as well as lipid composition
can be measured [10] – only however over a limited volume with typical dimensions of 2x2x2 cm3 in
clinical studies. The assessment of lipid composition is achieved by measuring the resonance peaks of
each lipid component, that is the methylene ((CH2)n) protons, the methyl (CH3) protons, the olefinic
protons, the α-methylene to carboxyl protons, the β-methylene to carboxyl protons, the α-olefinic
protons and the diacyk protons [6].
The knowledge of lipid composition is essential for investigations of lipid metabolism and, in the last
decade, MRS has been used to this purpose in many preclinical and clinical studies. From a data-
acquisition point of view, two main approaches can be distinguished in MRS: one where, prior to
excitation, water suppression pulses are used and the other where no water suppression is applied.
To date, however, no study has systematically and quantitatively investigated the effect of water
suppression on hepatic lipid quantification. For MR spectra, a means to determine the accuracy in
the quantification of resonance peaks is provided by the Crame´r-Rao Lower Bound (CRLB). Thus,
the CRLB calculated for each lipid resonance can be used as a metric when comparing the different
data-acquisition strategies.
Given the relevance of lipid composition in current research, it is of interest to determine the optimal
data-acquisition strategy in order to improve the quantification of hepatic lipids, in both preclinical
and clinical studies. The aim of this study was to investigate the effect of water suppression on the
quantification of lipid resonances in liver, as assessed by the LCModel [11], in a pre-clinical and a
clinical scenario. Data analysis was performed on MR spectra acquired in vivo at 4.7 T in mice and
at 3 T in patients.
2 Material and methods
2.1 Animals and Patients
Fifteen c57BL/6JRj female mice were used for the current study, including nine obese (ob/ob and
db/db) mice (Janvier Labs, Le Genest-Saint-Isle, France). The animals were five weeks old. For
MR experiments, animals were anaesthetized by intra-peritoneal injection of ketamine (55 mg/kg)
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and xylazine (5.5 mg/kg). MR measurements on each mouse were performed at different time points
(day 0, 14 and 28) in order to obtain spectra with different levels of hepatic fat overload, from small-
moderate fatty infiltration to severe fatty infiltration.
Eleven patients (age = 49 ± 12 years) suspected of presenting hepatic fat overload were included
in the clinical study. All preclinical and clinical experiments were approved by the Animal Ethics
Committee and Institutional Review Board, respectively.
2.2 In vivo 1H MRS
MR experiments on mice were performed using a 4.7 T MR scanner (47/40 USR Bruker Biospec,
Bruker BioSpin GmbH, Ettlingen, Germany) with a BGA12 gradient system (maximum strength of
400 mT/m) and a birdcage coil (72 mm inner-diameter). During experiments, the mouse respiration
rate was monitored using a fiber-optic pneumatic pillow (SA Instruments, Inc., Stony Brook, NY,
USA) to synchronize the acquisition with the respiratory frequency. Multi-slice T1-weighted RARE
images (RARE: Rapid Acquisition with Relaxation Enhancement [12]) were acquired for anatomical
localization, using the following parameters: TR=900 ms, TE=11.7 ms, 20 slices, a slice thickness of
1 mm, a field of view (FOV) of 5x5 cm2, a matrix of 192x192 and 3 signal averages. MRS was performed
using the double spin-echo Point REsolved SpectroScopy (PRESS) sequence [13] in a voxel of interest
(VOI) of 3x3x3 mm3 positioned in the right lobe of the mouse liver. For each mouse, two MR spectra
were acquired: i) one spectrum without water suppression (TR=4000 ms, TE=11 ms, 64 signal aver-
ages) and ii) one spectrum with water suppression (TR=2500 ms, TE=11 ms, 64/256 signal averages
(obese/control mice)). The VAPOR water suppression module was used (VAPOR: Variable pulse
Power and Optimized Relaxation delays [14]) with a spectral bandwidth of 150 Hz. Manual adjust-
ment of the water suppression pulse gains was performed on each mouse to optimize the suppression
of the water resonance.
MR experiments on patients were performed using a 3 T MR scanner (Verio, Siemens Medical So-
lutions, Erlangen, Germany) with a 32-channel torso coil. Multi-slice T2-weighted HASTE images
(HASTE: Half-Fourier Acquisition Single-shot Turbo Spin Echo [15]) were acquired for anatomical
localization, using the following parameters: TR=1000 ms, TE=96 ms, 30 slices, a slice thickness of
5 mm, FOV of 38x28 cm2 and an in-plane resolution of 1.5x1.2 mm2. MRS was performed using the
STimulated Echo Acquisition Mode (STEAM) sequence [16] in a VOI of 30x30x30 mm3 placed in
the right lobe of the liver avoiding large vessels. Similarly to the preclinical study, for each patient
two MR spectra were acquired: i) one spectrum without water suppression and ii) one spectrum with
water suppression. The water suppression module was the WET water suppression (WET: Water
suppression Enhanced through T1 effect [17]) and all MRS acquisitions were performed under breath
hold, with TR=4000 ms, TE=20 ms and 2 signal averages.
2.3 Analysis of MRS data and statistical analysis
All MR spectra were processed with the LCModel (Version 6.3-0L, Stephen Provencher, Oakville, ON,
Canada) without introduction of prior knowledge. Nine lipid resonances were identified, seven of those
lipid resonances were used in the current study, as illustrated in Figure 1. The Lip13 resonance area
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(originating from the (CH2)n protons at 1.3 ppm) represents the major resonance and accounts for
approximately 70% of the total lipid signal. For this reason, it is often used to quantify the fat content.
The other lipid resonances -with the exception of the Lip41 and Lip43 resonances (at 4.1 and 4.3 ppm,
respectively) corresponding to the glycerol chain- provide information on the fat composition [18–20].
The LCModel employs a flexible combination of Gaussian and Lorentzian lineshapes to model the
lipid resonances. For each resonance, the LCModel provides i) the ‘concentration’, measured as the
resonance area (also commonly referred to as ‘peak area’ in the case of non-overlapping signals) and
ii) the Crame´r-Rao Lower Bound (CRLB) [21], which yields an estimate of measurement reliability. It
should be noted that, when using the LCModel basis set for fat quantification, the user has no access
to the individual curve fitting of each resonance. In all calculations, only the resonances displaying a
CRLB<10% were considered.
The fat fraction (FF) was calculated from the MR spectra acquired without water suppression as the
ratio of the Lip13 resonance area ([Lip13]) relative to the sum of the water and Lip13 resonances
areas [4]. Preclinical and clinical spectra were each separated into two subsets considering an FF
threshold of 15%: the preclinical (clinical) subset with a high fat fraction (HFF) and the preclinical
(clinical) subset with a low fat fraction (LFF). A new parameter ‘R’ was introduced in order to assess
the impact of the water suppression on the Lip53+52 resonance, which is very close to the water
resonance. R was defined as the ratio of the resonance area of the Lip13 over the Lip53+52, that is,
R = [Lip13]/[Lip53+52]. The parameter R was evaluated in spectra with and without water suppres-
sion. In the ideal case, the value of R would not change with the water suppression. An increase of R
would indicate a reduction of the signal of the Lip53+52 due to the RF pulses of water suppression
module. This parameter was calculated for preclinical and clinical data, only for spectra presenting a
CRLB ¡10% for the Lip53+52 resonance.
In order to assess the effect of water suppression on the quantification of lipid resonances, a paired
t-test was used for comparison between the CRLBs of lipid resonances obtained with and without
water suppression. The level of significance was set at 5
3 Results
3.1 In vivo 1H MRS
Figure 1 shows an example of a non-water-suppressed (noWS) and a water-suppressed (WS) spectrum
acquired on a mouse liver with severe fatty infiltration (Figure 1, A and B, respectively), and on
a mouse liver with no fatty infiltration (Figure 1, C and D, respectively). Each lipid resonance is
indicated by the arrow on the non-water-suppressed spectrum on the mouse liver with severe fatty
infiltration (Figure 1, A). In the two spectra acquired on the mouse liver with severe fatty infiltration,
a similar spectral quality of the lipid resonances can be observed (Figure 1, A and B). In the spectra
acquired on the mouse liver without fatty infiltration (Figure 1, C and D), the major lipid resonance
(Lip13) is the only lipid resonance well above the noise level. An excellent water suppression was
obtained with the VAPOR water suppression module in combination with the manual adjustment of
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the water suppression pulse gains (Figure 1, B and D).
Figure 1: 1H MR spectra acquired on a mouse liver with a high fat fraction (FF=36.5%) without and with
water suppression (A and B, respectively), and on a mouse liver with a low fat fraction (FF=2.0%) without and
with water suppression (C and D, respectively). Each lipid resonance is indicated by the arrows on the spectrum
without water suppression (noWS) acquired on the mouse with high fat fraction. An efficient suppression of the
water resonance (spectra WS) was achieved with the VAPOR method.
Figure 2 shows a comparison of an MR spectrum acquired on a mouse liver at 4.7 T (Figure 2, A)
and on a patient liver at 3 T (Figure 2, B) with moderate fatty infiltration. In these two spectra, the
FF is comparable and approximately 15%. The preclinical and clinical spectra display similar spectral
features, validating the idea that similar acquisition strategies can be used for preclinical and clinical
MRS acquisitions on liver at these field strengths.
Figure 2: 1H MR spectra processed with the LCModel, acquired (A) at 4.7 T on a mouse liver with a fat fraction
of 15.0% and (B) at 3 T on a patient liver with a fat fraction of 13.0%.
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3.2 Analysis of MRS data and statistical analysis
The preclinical and clinical datasets were each separated into two subsets: one subset with low fat
fraction (LFF, FF<15%) and the other with high fat fraction (HFF, FF≥15%). The preclinical
(clinical) HFF subset included twenty-five (five) spectra, with a mean FF value of 26.9 ± 5.5%
(27.6 ± 7.8%). The preclinical (clinical) LFF subset included thirteen (six) spectra, with a mean
FF value of 1.6 ± 0.5% (6.0 ± 3.5%).
In the preclinical HFF subset (n=25), an excellent quantification of the major lipid resonance (Lip13)
was obtained in all cases with the CRLB values in the range of 1-2%, because of the large fat fraction.
The CRLB values of the Lip13 resonance were not improved (that is, the CRLB did not decrease) in
spectra acquired with water suppression. With respect to the smaller lipids resonances (Lip21, etc.)
a good quantification was also obtained because of the high fat content in the mice of this subset.
For instance, the Lip21 resonance is important in lipids quantification to differentiate saturated and
unsaturated fatty acids [18] (SFA and UFA, respectively). An example of the individual values of
the CRLBs for the Lip21 resonance in each mouse is shown in Table 1. Here, an effect of the water
suppression on the CRLB was observed, with an overall increase of the CRLB in spectra acquired
with water suppression (increase of 14% to 80%, in 20 out of 25 mice). In the remaining cases, a small
decrease, or no change, in the CRLB values was observed in spectra acquired with water suppression.
6
3.2 Analysis of MRS data and statistical analysis 3 RESULTS
CRLB(%) noWS CRLB(%) WS ∆CRLB(%) FF(%)
1 5 2 -150 19.9
2 6 4 -50 24.5
3 2 2 0 32.3
4 3 3 0 26.4
5 6 7 +14 17.6
6 3 4 +25 29.8
7 3 4 +25 19.7
8 3 4 +25 21.7
9 3 4 +25 25.5
10 2 3 +33 26.5
11 4 7 +43 26.4
12 3 6 +50 28.2
13 2 4 +50 30.3
14 2 4 +50 30.1
15 2 4 +50 30.9
16 7 16 +56 29.8
17 4 9 +56 30.3
18 2 5 +60 15.0
19 2 6 +67 34.8
20 1 3 +67 25.1
21 1 3 +67 36.5
22 2 9 +78 27.2
23 2 9 +78 36.1
24 1 5 +80 22.0
25 1 5 +80 35.5
Table 1: Crame´r-Rao Lower Bound (CRLB) values of the Lip21 resonance (2.02 ppm). MR spectra were
acquired with (WS) and without (noWS) water suppression in mice (n=25) with a hepatic fat fraction ≥ 15%.
Overall, an increase of the CRLB values of the Lip21 resonance is observed in the spectra acquired with water
suppression. The percentage difference between the CRLB with and without water suppression was calculated as
∆CRLB = 100 ∗ [CRLBWS − CRLBnoWS ]/CRLBWS. The last column shows the fat fraction calculated for
each spectrum. The increase of CRLB values with water suppression indicates that the best acquisition strategy
consists in acquiring MR spectra without water suppression.
In the preclinical LFF subset (n=13), the changes in the CRLB of the Lip13 resonance between
spectra acquired with and without water suppression did not exhibit a clear pattern (Table 2). In 50%
of the cases, a degradation of the quantification (i.e., higher CRLBs) was observed in spectra acquired
with water suppression. In the other 50% of cases, the opposite was observed. The Lip21 resonance
could not be reliably quantified (CRLB>10%) because of the low amount of fat. It should be noted
that, in the preclinical LFF subset, the number of averages used for the acquisitions (NA=256) with
water suppression was higher than in the case of the acquisitions (NA=64) without water suppression;
this could explain the lack of differences observed in the CRLBs.
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CRLB(%) noWS CRLB(%) WS ∆CRLB(%) FF(%)
1 20 5 -300 0.5
2 7 3 -133 2.0
3 4 3 -33 1.7
4 5 4 -25 1.4
5 4 4 0 1.9
6 5 5 0 0.8
7 3 3 0 1.5
8 2 3 +33 2.2
9 6 9 +33 1.4
10 3 6 +50 1.6
11 2 4 +50 1.9
12 3 10 +70 1.5
13 4 13 +70 2.0
Table 2: Crame´r-Rao Lower Bound (CRLB) values of the Lip13 resonance (1.3 ppm). MR spectra were
acquired with (WS) and without (noWS) water suppression in mice (n=13) with a small hepatic fat fraction.
The percentage difference between the CRLB with and without water suppression was calculated as ∆CRLB =
100∗ [CRLBWS−CRLBnoWS ]/CRLBWS. The last column shows the fat fraction calculated for each spectrum.
A similar analysis of the effect of water suppression on the lipid quantification was performed on
the clinical dataset. For the clinical HFF subset (n=5), an excellent quantification of the major lipid
resonance (Lip13) was obtained in spectra acquired with and without water suppression, with the
CRLB values in the range of 1-2% - except for one case (CRLB=9%). In three cases, no changes
were observed with water suppression. In two cases, the CRLB values were decreased with water
suppression (from 2% to 1%, and from 9% to 4%). Concerning the lipid resonances other than the
Lip13 resonance, it was possible to quantify reliably (CRLB<10%) the Lip21 resonance in both spec-
tra acquired with and without water suppression in four out of five patients. The CRLB value range
was 2-6% and 2-10% in spectra acquired with and without water suppression, respectively.
In the clinical LFF subset (n=6), the Lip13 was well quantified, in both spectra acquired with and
without water suppression. The range of the CRLBs obtained with and without water suppression was
1-4% and 2-5%, respectively. Overall, the water suppression had a negligible effect on the quantitation
of the Lip13 resonance: a maximum of 2% of absolute decrease was found in the CRLB with water
suppression in only one case.
In summary, the analysis of CRLB values shows that the strategy of using water suppression for liver
MR spectroscopy overall involves either no improvement, or a degradation of the spectral data.
The effect of the water suppression on the Lip53+52 resonance (at 5.3 ppm) is illustrated by the
calculation of the parameter R, defined in the Material and Methods section. For preclinical data, the
parameter R was evaluated for the spectrum with and without water suppression. In all cases, the R
value was higher for the spectrum acquired with water suppression (Figure 3). Similar results were
obtained for the clinical data.
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Figure 3: Graphical representation of the ratio R (R = [Lip13]/[Lip53+52]) calculated from spectra acquired
on mice presenting a high hepatic fat fraction (≥15%) with (WS) or without (noWS) water suppression. This
parameter was calculated only for spectra presenting a CRLB<10% for the Lip53+52 (5.3 ppm) resonance
(n=24). The connecting lines have been drawn to aid visual comparison.
For preclinical data (Table 3), in the HFF subset the paired t-test highlighted a strong correlation
between the strategy to acquire MR spectra with water suppression and a degradation of the quantifi-
cation of the lipid resonances (p-value range: 0.0002-0.0392), with the only exception of the Lip53+52
resonance (p-value = 0.0026). In the case of the LFF subset, no statistically significant difference
was found between the lipid resonances quantification obtained from spectra acquired with or without
water suppression (p-values of 0.30 and 0.85 for Lip09 and Lip13 resonances, respectively).
HFF LFF
n = 25 n = 13
WS noWS WS noWS
Lip09 0.0022** 0.3094
Lip13 0.0042** 0.8499
Lip16 0.0392*
Lip21 0.0002**
Lip23 0.0116*
Lip53+52 0.0026**
Table 3: P-values of paired t-test between the CRLB of each lipid resonance calculated from spectra acquired
with (WS) or without (noWS) water suppression. MR spectra were acquired in mice with a high fat fraction
(≥15%) and in mice a low fat fraction (<15%). The CRLB of lipid resonances are always lower without water
suppression, except for the Lip53+52 resonance. (**) = p-value < 0.01 ; (*) = p-value < 0.05.
For clinical data, in the HFF subset there was no statistically significant difference between the
Lip13 resonance quantification obtained from spectra acquired with or without water suppression (p-
values of 0.14). The same result applied to the quantification of the Lip21 resonance (p-value of 0.27).
In the LFF subset, for the Lip13 (the only lipid resonance that could be reliably quantified) the paired
9
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t-test showed a correlation between the strategy to acquire MR spectra with water suppression and
an improvement in the quantification of the lipid resonances (p-value = 0.006). However, since the
CRLB values are similar in both strategies, we can consider that this improvement is negligible. In
summary, the statistical analysis of our results shows that the strategy of using water suppression
for liver MR spectroscopy involves either a deterioration of spectral data or, in best case scenario, no
improvement.
4 Discussion
In the current study, a quantitative assessment of the impact of water suppression on the hepatic lipid
quantification was performed. To date, in both preclinical and clinical studies there is no established
approach with respect to the data acquisition of MR spectra in liver. In particular, to determine the
fat percentage and composition, the experimental protocol includes in some cases two MR spectra
(one with and the other without water suppression) [3,9,14,18,20,22–25] and in other cases only one
MR spectrum (without water suppression) [?, 2, 4, 6, 8, 19, 26–32] . In the current study, MR spectra
with and without water suppression were acquired in patients, at 3 T, and in mice, at the moderate
field of 4.7 T. The CRLB of each lipid resonance, evaluated by the LCModel, was used as a metric
to determine the effect of water suppression on the hepatic lipid quantification. The CRLBs obtained
from the analysis of spectra acquired with water suppression were compared to those obtained from
spectra without water suppression. The analysis of CRLB of the lipid resonances showed that there
is no benefit in acquiring the MR spectrum with water suppression since it does not improve the
quantification of these resonances. In addition, water suppression could result in degradation of the
lipid resonance nearby the water resonance. Thus, the results of the current study indicate that -for
the experimental conditions of the current work - it is possible to shorten the experimental protocol
without loss of information by not acquiring an additive MR spectrum with water suppression.
It should be noted that the experimental conditions of this study - in particular the magnetic field
strength- are similar to those of previous studies performed in clinical settings, where the 3 T MRI sys-
tems are becoming increasingly common [6], and in preclinical models. Interestingly, many preclinical
works in mouse and rat liver have been performed at moderate magnetic field strengths [18,26,29,33].
This is in stark contrast to MR spectroscopy of brain where the majority of the preclinical studies is
performed at magnetic field strength ≥ 7 T [14]. Thus, the results of the current study are relevant
and of interest to the MR scientists working on liver spectroscopy both in clinical and preclinical
models.
With respect to the data analysis of in vivo MR spectra of hepatic lipids, different dedicated software
and models are currently used, without a well-established method. This is due to the fact that the
precise line shape of the lipid resonances is not known a priori. As a matter of fact, given the complex
structure of the triglyceride molecule, quantum mechanics simulations based on the density matrix
formalism can model the spectral shape of lipid resonances only to a certain extent. As a consequence,
current fitting methods employ empirical approaches. In particular, the software used in the current
study (LCModel) employs a combination of Gaussians and Lorentzians for each lipid resonance to
determine the area under the resonance peak. It should be noted here that a different scenario char-
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acterizes the data analysis of MR spectra acquired in organs other than liver. In MRS of brain and
prostate, for instance, it is possible to model the line shapes corresponding to each metabolite (gluta-
mate, myoinositol citrate, etc.) with a high level of precision using quantum mechanics simulations;
as a result, it is possible to use this information as a priori knowledge in data fitting.
One limitation of the current study is that, to assess the impact of water suppression on hepatic lipid
quantification, the only metric employed was the CRLB values. The limitations of the CRLB values,
well known and nicely described in the literature [34, 35], might have an impact on the assessment of
the lipid quantification in the low fat fraction scenario. On the other hand, there is no established
metric available to validate the CRLB results for the two specific resonances (Lip13 and Lip09) that
have been quantified in the low fat fraction cases; further studies would be needed to elucidate this
issue, with a specific, tailored metric.
The water suppression module that is typically used on clinical scanners consists of 2 to 4 CHESS
(CHemical Shift-Selective) pulses, whereas more sophisticated approaches are available on preclinical
scanners. The water suppression module employed in the current study on the clinical scanner was
WET with 3 CHESS pulses, and on the preclinical scanner was VAPOR with 7 CHESS pulses. For
the MR data acquisition performed on the clinical scanner, no manual adjustment of the water sup-
pression was done. As a result, incomplete water suppression was observed in some spectra. On the
contrary, in the preclinical experiment the use of VAPOR –in addition to the manual adjustment of
the water suppression pulse gains - resulted in excellent water suppression. It should be noted that in
most clinical studies, due to time constraints, manual adjustments -if available- are rarely performed.
In the current study, a systematic effect was observed on the quantification of the Lip53+52 resonance
in the MR spectra acquired with and without water suppression, on mice. The parameter R, defined
in the Material and Methods section, was used to quantify this effect. The value of R with water
suppression was lower than the value of R without water suppression. Since there is no ground truth
for the value of the Lip53+52 resonance in our experimental conditions, from the current data it is not
possible to determine which is the best approach to quantify this resonance. As mentioned previously,
when considering the literature regarding preclinical studies performed at similar field strength (3 T-
4.7 T), there is no established method of data acquisition (with or without water suppression) for the
lipid quantification. In some preclinical studies, MR spectra were acquired with water suppression,
however the Lip53+52 resonance was not used in the quantification, since it could have been partially
suppressed by the water suppression [33]; in other studies, on the other hand, no water suppression
was used [23–27] . Based on the results of the current study, it is not clear which is the most beneficial
approach for the quantification of the Lip53+52, at the moderate field of 4.7 T.
In clinical studies of liver pathologies the biomarker of interest is the fat content, which can be de-
termined using the major lipid resonance at 1.3 ppm. For instance, a biomarker for the diagnosis of
steatosis is based on a 5% fat content threshold. The hepatic lipid composition is rarely assessed;
however, the quantification of hepatic lipid composition could be of great interest to gain insight into
the lipid metabolism in liver. Intuitively, it might seem natural to acquire MR spectra in liver with
the water suppression, as it is done in MRS of brain, to improve the detection of the smaller lipid
resonances. The results of the current study show that there is no improvement in the quantification
of lipid resonances by employing the water suppression; this applies to the quantification of both
11
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fat content as well as fat composition. As a consequence, the clinical protocol can be shortened by
acquiring only the non-water-suppressed MR spectrum.
5 Conclusion
The results of the current study indicate that, for quantification of lipid resonances in liver, it is ad-
vantageous to perform MR spectroscopy without water suppression. This applies to the quantification
of fat fraction as well as fat composition, both in preclinical and clinical scenario (at moderate fields).
As a consequence, the preclinical and clinical protocols can be shortened by only acquiring an MR
spectrum without water suppression.
Appendix
An additional data analysis of the MR spectra was performed in order to provide further insight into
the current study. In the preclinical (clinical) HFF subset, the mean value of the full width at half
maximum (FWHM) of the water resonance was 53 ± 7 Hz (46 ± 18 Hz). In the preclinical (clinical)
LFF subset, the mean value of the FWHM of the water resonance was 59 ± 13 Hz (32 ± 9 Hz). The
FWHM observed in the preclinical HFF and LFF subsets is in agreement with the FWHM value found
in a previous study performed at 4.7 T on mice [18]. The FWHM observed on the clinical HFF subset
is higher than the value (FWHM ≈ 30 Hz) found in a previous study at 3 T on patients [32]. On the
other hand, the FWHM observed on the clinical LFF subset is in agreement with the value found in
Ref. [32].
The noise level measured on the preclinical HFF subset was 163 ± 31 (a.u.) without water suppression
and 179 ± 44 (a.u.) with water suppression. Thus, it appears that the VAPOR water suppression did
not affect the noise level.
The quantification of the lipid composition was calculated using the Corbin et al. algorithm [18] on the
HFF subsets (preclinical and clinical) with and without water suppression. It should be pointed out
that in the Corbin method, the UFA fraction is calculated as: 100 ∗ 3/4 ∗ [Lip21]/[Lip09] and the SFA
fraction is calculated as: 100−UFA. On the preclinical HFF subset, the results were of SFA=29.23%
and UFA=70.77% (in both cases the standard deviation was of 4.6%) without water suppression. With
water suppression the results were SFA=30.88% and UFA=69.12% (in both cases the standard devia-
tion was of 5.29%). On the clinical HFF subset, the quantification of the lipid composition yielded the
values of SFA=43.25% and UFA=56.75% (standard deviation = 6.08%) without water suppression
and SFA=39.65% and UFA=60.35% (standard deviation = 5.60%) with water suppression. Thus, the
values of saturated and unsaturated fatty-acid fractions obtained from spectra with water suppression
were comparable to those from spectra without water suppression, both in clinical and preclinical data.
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